Learn More
Invitrogen™ Human PACT (aa 1-70) Control Fragment Recombinant Protein
Descripción
Highest antigen sequence indentity to the following orthologs: Mouse (96%), Rat (96%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-65134 (PA5-65134. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Especificaciones
Especificaciones
| Número de acceso | O75569 |
| Concentración | ≥5.0 mg/mL |
| Para utilizar con (aplicación) | Blocking Assay, Control |
| Formulación | 1 M urea, PBS with no preservative; pH 7.4 |
| ID de gen (Entrez) | 8575 |
| Nombre | Human PACT (aa 1-70) Control Fragment |
| Cantidad | 100 μL |
| Estado normativo | RUO |
| Alias de gen | AV120107; DYT16; HSD14; HSD-14; interferon-inducible double stranded RNA-dependent protein kinase activator A; interferon-inducible double-stranded RNA-dependent protein kinase activator A; lear; PACT; PKR associated protein X; PKR-associated protein X; PKR-associating protein X; PRK; PRKRA; protein activator of interferon induced protein kinase EIF2AK2; protein activator of the interferon-induced protein kinase; protein kinase, interferon inducible double stranded RNA dependent activator; protein kinase, interferon-inducible double stranded RNA dependent activator; protein kinase, interferon-inducible double stranded RNA-dependent activator; protein kinase, interferon-inducible double-stranded RNA-dependent activator; RAX |
| Nombre común | PACT |
| Mostrar más |
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.